Genabio -Model SARS-CoV-2 -Antigen Lateral Flow Test
Genabio® SARS-Cov-2 Antigen Lateral Flow Test is a rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein antigen of SARS-CoV-2.
Most popular related searches
- Accurate: Clinical data from US have shown 86.4% sensitivity and 100% specificity.
- Dependable: Manufactured in ISO13485 accredited facility with daily capacity up to 2 million kits.
- Convenient: Everything is included in the kit to get COVID-19 result in 15 minutes.